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Abstract
Background: Worldwide distribution of surgical interventions is unequal. Developed countries account for the majority of
surgeries and information about non-cardiac operations in developing countries is scarce. The purpose of our study was to
describe the epidemiological data of non-cardiac surgeries performed in Brazil in the last years.
Methods and Findings: This is a retrospective cohort study that investigated the time window from 1995 to 2007. We
collected information from DATASUS, a national public health system database. The following variables were studied: number
of surgeries, in-hospital expenses, blood transfusion related costs, length of stay and case fatality rates. The results were
presented as sum, average and percentage. The trend analysis was performed by linear regression model. There were
32,659,513 non-cardiac surgeries performed in Brazil in thirteen years. An increment of 20.42% was observed in the number of
surgeries in this period and nowadays nearly 3 million operations are performed annually. The cost of these procedures has
increased tremendously in the last years. The increment of surgical cost was almost 200%. The total expenses related to
surgical hospitalizations were more than $10 billion in all these years. The yearly cost of surgical procedures to public health
system was more than $1.27 billion for all surgical hospitalizations, and in average, U$445.24 per surgical procedure. The total
cost of blood transfusion was near $98 million in all years and annually approximately $10 million were spent in perioperative
transfusion. The surgical mortality had an increment of 31.11% in the period. Actually, in 2007, the surgical mortality in Brazil
was 1.77%. All the variables had a significant increment along the studied period: r square (r
2)=0.447 for the number of
surgeries (P=0.012), r
2=0.439 for in-hospital expenses (P=0.014) and r
2=0.907 for surgical mortality (P=0.0055).
Conclusion: The volume of surgical procedures has increased substantially in Brazil through the past years. The expenditure
related to these procedures and its mortality has also increased as the number of operations. Better planning of public
health resource and strategies of investment are needed to supply the crescent demand of surgery in Brazil.
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Introduction
It was recently estimated that every year 234.2 millions of
surgeries are performed around the world. The authors, however,
argued that this number is probably underestimated because of
incomplete data and unregistered interventions [1]. Moreover, the
authors observed that worldwide distribution of surgical interven-
tions is unequal. Developed countries account for the majority of
surgeries and information about non-cardiac operations in
developing countries is scarce. Indeed, in developed countries
surgical procedures are associated to mortality rates ranging from
0.4 to 0.8% and morbidity from 3 to 16% whereas in developing
countries there is a completely different picture: mortality rate
ranges from 5 to 10% [1].
Along the last decades, several strategies have been suggested to
be effective in the reduction of perioperative complications [2–18].
Table 1. However, in spite of all medical and technological
innovation, surgical mortality and morbidity remain above
desirable levels and, more importantly, there is a huge worldwide
variation suggesting that application of standards of evidence
regarding to perioperative care is not adequate in some countries.
In the last decade, economical growth has significantly changed
lifestyle and characteristics of the population of developing
countries. The increase of life expectancy associated to the
changes in demographic characteristics of population, besides the
technological and medical advances, may have resulted in
modifications on the number of surgeries, surgical mortality,
number of days of in-hospital stay and health expenditure. The
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10607purpose of our study was to evaluate the epidemiological and
economical aspects of non-cardiac surgeries performed in Brazil in
the last years.
Methods
This is a retrospective study that investigated national data
about a cohort of individuals submitted to non-cardiac surgery in
Brazil in the last years. The study was designed and conducted at
the Heart Institute from the University of Sao Paulo, Brazil. The
data were collected from DATASUS (www.datasus.gov.br), a
national open-access public health system database, organized and
maintained by the government. We selected surgical hospitaliza-
tions information from DATASUS based on its relevance and its
potential contribution to provide epidemiological information
regarding non-cardiac surgeries performed in Brazil. The variables
studied were: number of surgeries, in-hospital expenses, blood
transfusion related cost, period of hospitalization (length of stay)
and case-fatality rates.
We accessed DATASUS database on January of 2009 and
collected information of all medical hospitalizations. In DATA-
SUS, every hospitalization is described by the corresponding name
of procedure and a respective code number. The database
contained 3,209 types of procedures related to all areas of
medicine, 785 of them were classified as non-surgical hospitaliza-
tions and were excluded from our analysis. Surgical interventions
not in the focus of this study, such as cardiac surgery, ambulatory
surgery, minor surgery (eg.: diagnostic procedures), biopsy and
birth delivery were excluded as well. Occasionally, a surgical
procedure was found in duplicate in the database with the same
name and a different code number. In this case, the information of
repeated procedures was grouped into a single category. After that,
1,568 non-cardiac surgeries were selected and constituted the
database of the present study.
In our original database, the selected information was available
from 1992 to 2007, but we decided to exclude data previous to
1995 because of the different monetary system used before this
date in Brazil, which jeopardized the comparison of economical
data between these periods. The final time-window of our registry
was from 1995 to 2007.
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Board of Hospital das Clinicas - University of
Sao Paulo Medical School (number 0952/09). Since all the
information of the study was collected from an open-access
database, inform consent was not obtained in our study due to no
potential patient identifiers in dataset.
Statistical analysis
For each studied variable, we obtained a single dataset where
the information was represented with the corresponding year in
column and surgical procedure in row. We found a significant
number of missing data in the original database provided by
DATASUS. The surgical procedures containing missing data
were not included in the statistical analysis. A descriptive
statistical analysis was performed and the results were presented
as sum, average and percentage. The trend analysis was
performed by linear regression model. All the statistical analyses
were performed by the statistical program R – project for
statistical computing and SPSS version 17.0. We adopted as
statistical significance, value of P,0.05 for all the tests
performed.
Table 1. Effective strategies to reduce perioperative
complications.
Perioperative evaluation/risk estimation based on clinical algorithms and
guidelines [2–4]
Beta-blockade in special clinical settings [5–10]
Statins for patients submitted to vascular surgery [11–14]
Clinical and cardiological monitorization in ICU for high risk patients [2,15]
Intensive glucose control [16,17]
Surveillance with cardiac biomarkers (cardiac troponin) [15,18]
doi:10.1371/journal.pone.0010607.t001
Table 2. Results of studied variables and its changes among the time-window from 1995 to 2007.
Year
Number of
Surgeries
Number of surgeries/1,000
inhabitants
Total in-hospital
expenses (U$)
Blood transfusion
cost (U$)
Length of stay
(days) Mortality
1995 2,374,785 14.95 430,863,966.29 4,854,739.24 4.36 1.35%
1996 2,240,815 13.89 437,971,979.33 4,770,430.97 4.46 1.46%
1997 2,152,741 13.14 434,812,544.63 5,153,020.23 4.37 1.53%
1998 2,205,637 13.27 520,001,042.93 6,263,305.91 4.34 1.54%
1999 2,359,313 13.98 674,983,936.25 7,274,983.84 4.31 1.57%
2000 2,505,951 14.63 698,072,190.81 7,591,026.47 4.07 1.53%
2001 2,412,859 13.88 731,001,821.51 7,805,656.50 4.16 1.61%
2002 2,578,830 14.63 824,119,175.40 7,809,363.30 4.12 1.58%
2003 2,672,604 14.95 936,352,419.05 7,743,472.55 4.06 1.65%
2004 2,748,461 15.18 1,063,584,652.73 9,036,363.77 3.99 1.68%
2005 2,750,971 15.00 1,140,509,016.19 10,375,029.49 3.91 1.78%
2006 2,796,745 15.07 1,158,672,620.45 9,953,549.40 3.82 1.74%
2007 2,859,801 15.24 1,273,316,507.84 10,140,843.08 3.83 1.77%
Total 32,659,513 10,324,261,873.41 98,771,784.73
doi:10.1371/journal.pone.0010607.t002
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surgical hospitalizations were analyzed after correction of its values
to monetary depreciation in the period. For this purpose, we used for
correction the national economic index, specific for health costs. The
value of all expenses were converted from Real to US dollar 2009
(The conversion rate was R$1.76 for $1.00 at the time of the study).
Results
We analyzed 32,659,513 non-cardiac surgeries performed in
Brazil during thirteen years. From 1995 to 2007 we observed an
increment of 20.42% in the number of surgical procedures. After
adjustment for the population growth, we observed a consistent
increase in the number of surgeries per 1,000 inhabitants in the
studied period, remarkably from 2001 to 2007. In addition, we
observed also a progressive increase in case-fatality rates and in the
expenses related to surgical interventions. Table 2.
We observed an increment of total in-hospital expenses as well
as blood transfusion related costs in association with surgical
interventions. The total in-hospital expenses related to surgical
hospitalizations had an increment nearly to 200% in a period of 13
years reaching the comprehensive value of more than $10 billions
of dollars in all these years (more than $1.27 billions of dollars per
year). In average, $ 445.24 dollars were spent per patient per
surgical procedure. Similarly, the same pattern of increment was
observed in expenditures related to perioperative blood transfu-
sions. There was an increment in the transfusional cost of more
than 100% in the period and the entire cost related to blood
transfusion was almost $ 98 millions of dollars in all these years.
Table 2.
The case-fatality rates related to these non-cardiac surgeries
increased 31.11% during the last thirteen years. The length of stay
was the single variable that reduced through the last years. In
average, the length of stay had a decline of 12.15%. Table 2.
Trends analysis
Globally, the trend analysis showed that the number of surgeries
per 1,000 inhabitants and the surgical mortality had a statistically
significant increment along the past thirteen years (r
2=0.447,
P=0.012 and r
2=0.907, P=0.005, respectively). On the other
hand, the length of stay had a significant decline in the period
(r
2=0.928, P=0.001). Figure 1.
Economical analysis adjusted for monetary depreciation
For the economical analysis of expenses related to surgical
hospitalizations, we used the average cost of the surgical procedures.
All the values were corrected to monetary depreciation that occurred
in the studied period. For this correction, we used the national
economic index, specific for health costs. The year of 1995 was used
as monetary reference. Generally, there was a reduction of surgical
expenses per procedure in the first two years, in 1996 and 1997, as
observed in our database. After that, we observed a progressive
increase of surgical expenses through the last years. Table 3.
The trend analysis of surgical hospitalization expenses was
statistically significant and demonstrated a progressive increase of
in-hospital expenses associated to surgical procedures (r
2=0.439,
P=0.014). Regarding the increment of blood transfusion expenses
observed during the studied period, it disappeared after adjust-
ment for monetary depreciation. (r
2=0.014, P=0.30). Figure 2.
Discussion
Our results indicated that the volume of non-cardiac surgeries
performed in Brazil has increased substantially through the past
years. In parallel, the increase of the number of the operations
implicated in the elevation of total hospital expenses related to
these surgical procedures. The surgical mortality on our registry
Figure 1. Trends analysis results. A- Number of surgery per 1,000
inhabitants. B – Mortality. C- Length of Stay.
doi:10.1371/journal.pone.0010607.g001
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epidemiology of surgeries performed in Brazil is different from
international data. Annually, there are performed almost 38
millions of surgeries in United States of America, and 7 millions of
surgeries are estimated to be performed annually in Europe. In our
registry, Brazil performed nearly 3 millions of non-cardiac
surgeries yearly, a number much lower compared to developed
countries. These numbers may indicate unequal access to surgical
treatment between these countries.
In a previous study of the estimation of the global volume of
surgery, Weiser et al [1] described a disparity in access to surgery
between rich and poor countries and that there is a close relation
between per-head expenditure on health and country’s annual
surgical rate (r
2=0.868, P,0.0001). Countries with middle ($401–
1,000) and high-expenditures per capita ($.1,000) on health care
were responsible for 73.6% of surgical procedures worldwide,
whereas the countries with poor (,$100) and low-expenditures
($101–400) provided only 26.5% of operations but accounted for
69.8% of the global population.
In the last decades, Brazil showed a great economical
development that was paralleled by a significant modification in
the health characteristics of the population. There was a reduction
in perinatal mortality and an increase in life expectancy [19]. In
spite of the increment of life expectancy, investment of the
government in the public health system in Brazil remains below
desired levels. The analysis of health expenditure ratios in Brazil
demonstrated that total expenditure on health as percentage of
Brazilian gross domestic product showed an increase since the last
report in 2000 [19]. However, regardless of the increment from
7.2% in 2000 to 7.5% in 2006, it remains below the global rate of
8.7%. In addition, the public expenditure on health was
responsible for only 48% of total expenditure on health,
corresponding to only 7.2% of total public expenditure, signifi-
cantly lower than the global value of 14.3%. The total expenditure
on health per capita per year, in Brazil is, in average, $ 427. From
this amount, only $ 204 were invested by the government, a value
much inferior when compared to global expenditure of $ 429 per
capita or to the investment from developed countries like United
States of America ($ 3,076 per capita) or Europe ($ 1,350 per
capita) [19]. In addition to our data, these numbers indicate that
the public investment on health in Brazil is significantly lower than
international patterns.
On the other hand, the results of our registry suggested that
surgical procedures in Brazil are associated to higher mortality rate
and lower hospital expenditure per operation when compared to
developed countries. In average, the mean value spent per surgical
procedure was $ 445.24 in Brazil, whereas surgical hospital
expenses accounts for more than $ 2,000 per operation in a
canadian institution [20] or superior to $ 9,000 in an american
institution [21]. Regarding to case-fatality rates, we found that the
perioperative mortality in Brazil is two times greater than
american rates [21] and almost nine times higher than canadian
rates [20]. The findings related to the length of stay in our registry
are comparable to international data.
According to the categories established by Weiser and cols in
their study [1], Brazil would be classified as a middle-expenditure
country with an estimated rate of surgery of 42.48 operations per
1,000 inhabitants. However, in our study, despite the non
Table 3. Economical data of surgical procedures performed
from 1995 to 2007 adjusted for monetary depreciation.
Year
Mean hospital expense per
surgery (U$)
Mean transfusion cost per
surgery (U$)
1995 181.43 2.04
1996 132.44 1.44
1997 115.83 1.37
1998 127.88 1.54
1999 150.33 1.62
2000 142.37 1.55
2001 154.24 1.65
2002 160.56 1.52
2003 169.89 1.40
2004 178.48 1.52
2005 182.25 1.66
2006 176.57 1.52
2007 184.99 1.47
The values were corrected to monetary depreciation in the period. The year
1995 was used as reference.
doi:10.1371/journal.pone.0010607.t003
Figure 2. Trend analysis of economical data adjusted for
monetary depreciation. A – Mean in-hospital expense per surgery. B-
Mean transfusion cost per surgery.
doi:10.1371/journal.pone.0010607.g002
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deliveries, we found that only 15.24 surgical procedures were
performed annually per 1,000 inhabitants. The results of our study
in conjunction with these numbers suggest that, in Brazil, the
access to surgical interventions is deficient, there is an insufficient
number of surgeries performed, and the surgical outcome is worse.
This picture requires more attention and investment to obtain
better results.
Study limitations
Limited information is available regarding non-cardiac surgery
outcomes, the overall number of operations and surgical morbidity
and mortality. To our knowledge, this is the pioneer registry
designed to evaluate epidemiological national data about non-
cardiac surgeries. The major limitation of our study is that it is a
retrospective study based on information collected from an
administrative database. The use of data based on administrative
information is susceptible to potential sources of bias. The feed of
information into dataset is usually performed by administrative
technicians and non-medical professionals and the system is
susceptible to typing errors, wrong data interpretation or missing
data. We sought to exclude the missing data for the analysis in
order to minimize the errors of the results. Another limitation is
that the time-window of our study was only thirteen years and it
was impossible to make future estimations.
However, this is the first national registry about non-cardiac
surgeries that provided important information about epidemio-
logical and economical aspects of operations performed in Brazil.
The crescent increment in the number of surgeries associated to
the increasing of global life expectancy may increase substantially
the burden of surgical interventions in the next years. This
elevated number of operations performed annually and its high
mortality has emerged as a global public-health challenge. The
knowledge of epidemiological data of surgeries performed in each
country and its progression over the years is essential to define
strategies and priorities in public health policy. Our data may
contribute to this debate and also help to a better planning of
public health investment in Brazil.
Conclusion
The volume of surgical procedures has increased substantially in
Brazil through the past years. The expenditure related to these
procedures and its mortality has also increased as the number of
operations. Better planning of public health resource and strategies
of investment are needed to supply the crescent demand of surgery
in Brazil.
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